Efficacy and Safety of the Lysobact Complete Spray®, Tantum Verde® and Pharyngal® Oromucosal Spray in the Treatment of Acute Sore Throat

Inclusion Criteria: * Patients with acute tonsillo-pharyngitis symptoms in common cold and by using a scale-based symptom Tonsillo-Pharyngitis Assessment (TPA) as an objective finding of pharyngeal infection, with a score of ≥5 * Patients who will be treated only on a symptomatic treatment basis, and with a prescribed a oropharyngeal spray * Patients, 18 years of age and above, who provided an informed consent * Patients with a sore-throat of recent onset, symptoms initiated ≤48 hours * Patients with sore throat pain rated ≥66 mm on the Sore Throat Pain Intensity Scale (STPIS) * Patients with difficulty in swallowing rated ≥50 mm on Difficulty Swallowing Scale (DSS) * Patients with a sensation of swollen throat rated ≥33 mm on the Swollen Throat Scale (SwoTS) Exclusion Criteria: * Patients who had any previous (within 4 hours prior to screening examination) throat lozenge treatment/use * Patients who had used any flu-preparation which contains any analgesic ingredient such as paracetamol, ibuprofen or acetylsalicylic acid (ASA) along with a decongestant * Patients who had analgesic use (any) 4 hours prior to the screening examination * Patients who are prescribed an antibiotic use before the screening visit and are entitled to use antibiotics during the course of this non-interventional study * Patients with a known hypersensitivity to active/inactive ingredients of medications which is prescribed for the symptomatic treatment of sore throat * Patients with known hypersens…